Colorado Biolabs, Inc. (CBL) and Overseas Healthcare Ltd (Overseas) are excited to announce the launch of Fe Daily, a new product designed to address
anemia in Africa. Fe Daily incorporates
CBL's Proferrin® brand Heme iron polypeptide and will be available for purchase across the continent starting in 2024.
Adam Kashenberg, CEO of Colorado Biolabs, highlighted the critical issue of anemia in Africa and expressed enthusiasm about the collaboration with
Overseas Healthcare. "Both companies have long aimed to support the residents of Africa, and we are delighted to begin offering Proferrin and Fe Daily to those in need this year," Kashenberg stated.
Overseas Healthcare, a prominent Indian pharmaceutical firm, plans to make Proferrin® accessible throughout Africa by the end of 2025 under the Fe Daily brand. Managing Director D.P. Soni emphasized the company's commitment to alleviating anemia in both Asia and Africa. "We want to bring the remarkable benefits of Fe Daily to all who suffer from anemia in these regions," Soni commented.
Proferrin® brand Heme Iron Polypeptide (HIP) from CBL is known for its superior ability to boost serum iron levels, achieving up to 23 times greater efficacy than traditional iron salts on a milligram-per-milligram basis. This high efficiency means that effective iron supplementation can be achieved with lower doses, minimizing gastrointestinal side effects. Additionally, HIP does not require the addition of
Vitamin C for absorption, which is noteworthy because combining
iron and Vitamin C can cause oxidative stress in the stomach lining, potentially leading to
ulceration.
Manufactured in the United States by Colorado Biolabs, Inc., Proferrin® iron supplements were first introduced to the U.S. market in 2001. Today, Proferrin® is also available in Canada, the UAE, Puerto Rico, and the Philippines.
By the end of 2025, Overseas Healthcare aims to ensure that Fe Daily is widely available across Africa, providing a reliable solution for anemia and improving the quality of life for many individuals.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!
